Cargando…

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Diminished overall survival rate of non-Hodgkin lymphoma (NHL) patients treated with a combination regimen of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) has been recently linked to recurrent somatic mutations activating FOXO1. Despite of the clinical relevance of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyrzynska, Beata, Dwojak, Michal, Zerrouqi, Abdessamad, Morlino, Giulia, Zapala, Piotr, Miazek, Nina, Zagozdzon, Agnieszka, Bojarczuk, Kamil, Bobrowicz, Malgorzata, Siernicka, Marta, Machnicki, Marcin M., Gobessi, Stefania, Barankiewicz, Joanna, Lech-Maranda, Ewa, Efremov, Dimitar G., Juszczynski, Przemyslaw, Calado, Dinis, Golab, Jakub, Winiarska, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927521/ https://www.ncbi.nlm.nih.gov/pubmed/29721381 http://dx.doi.org/10.1080/2162402X.2017.1423183

Ejemplares similares

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
por: Dwojak, M, et al.
Publicado: (2015)

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
por: Winiarska, Magdalena, et al.
Publicado: (2014)

Inhibition of thioredoxin-dependent H(2)O(2) removal sensitizes malignant B-cells to pharmacological ascorbate
por: Graczyk-Jarzynka, Agnieszka, et al.
Publicado: (2018)

Selection of an optimal promoter for gene transfer in normal B cells
por: Winiarska, Magdalena, et al.
Publicado: (2017)

Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
por: Miazek-Zapala, Nina, et al.
Publicado: (2021)

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
por: Goral, Agnieszka, et al.
Publicado: (2022)

New insights into redox homeostasis as a therapeutic target in B-cell malignancies
por: Graczyk-Jarzynka, Agnieszka, et al.
Publicado: (2017)

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
por: Ramji, Kavita, et al.
Publicado: (2022)

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
por: Barankiewicz, Joanna, et al.
Publicado: (2021)

CRL4(CRBN) E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
por: Barankiewicz, Joanna, et al.
Publicado: (2022)

Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives
por: Bobrowicz, Malgorzata, et al.
Publicado: (2019)

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
por: Bajor, Malgorzata, et al.
Publicado: (2018)

A conspiracy of glioma and endothelial cells to invade the normal brain
por: Zerrouqi, Abdessamad, et al.
Publicado: (2011)

Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
por: Wachowska, Małgorzata, et al.
Publicado: (2011)

Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland – a report of the Polish Lymphoma Research Group
por: Kalinka, Ewa, et al.
Publicado: (2019)

Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma
por: Trzeciecka, Anna, et al.
Publicado: (2015)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model
por: Sokolowska, Olga, et al.
Publicado: (2022)

Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate
por: Zapala, Piotr, et al.
Publicado: (2017)

Immune Evasion as the Main Challenge for Immunotherapy of Cancer
por: Zagozdzon, Radoslaw, et al.
Publicado: (2022)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy
por: Firczuk, M, et al.
Publicado: (2013)

CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies
por: Kubacz, Matylda, et al.
Publicado: (2022)

Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern
por: Dybowski, Bartosz A., et al.
Publicado: (2018)

Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo
por: GABRYSIAK, MAGDALENA, et al.
Publicado: (2016)

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy
por: Polak, Anna, et al.
Publicado: (2016)

A stone pushed back to the collecting system – long therapeutic path in centers with limited access to flexible instruments
por: Bres-Niewada, Ewa, et al.
Publicado: (2018)

Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma
por: Wolosz, Dominika, et al.
Publicado: (2019)

Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma
por: Wątek, Marzena, et al.
Publicado: (2019)

Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia
por: Fidyt, Klaudyna, et al.
Publicado: (2019)

SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism
por: Polak, Anna, et al.
Publicado: (2020)

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2022)

Cholesterol restricts lymphotoxin β receptor-triggered NF-κB signaling
por: Banach-Orłowska, Magdalena, et al.
Publicado: (2019)

Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma
por: Kusowska, Aleksandra, et al.
Publicado: (2022)

Prospects for NK Cell Therapy of Sarcoma
por: Lachota, Mieszko, et al.
Publicado: (2020)

P611: CD37 AS A MOLECULAR TARGET FOR CAR-T CELLS AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA
por: Kusowska, Aleksandra, et al.
Publicado: (2023)

Restriction of memory B cell differentiation at the germinal center B cell positive selection stage
por: Toboso-Navasa, Amparo, et al.
Publicado: (2020)

Positive Selection in the Light Zone of Germinal Centers
por: Nakagawa, Rinako, et al.
Publicado: (2021)

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
por: Fidyt, Klaudyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_15h7vb7jm339r8t5k6v8ri2qa4